uridine monophosphate has been researched along with Viremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alloway, RR; Eckman, MH; Sherman, KE; Thakar, CV; Woodle, ES | 1 |
| Agüero, J; Alvarez, S; Ayesa, R; Cabezas, J; Calleja, JL; Chueca, N; Cobo, C; Crespo, J; Crespo-Facorro, B; Cuadrado, A; Echevarría, S; Fortea, JI; Garcia, F; Llerena, S; Lopez-Hoyos, M; Mateo, M; Pallás, JR; Pellón, R; Setién, E | 1 |
1 trial(s) available for uridine monophosphate and Viremia
| Article | Year |
|---|---|
Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Disease Eradication; Environmental Exposure; Female; Fluorenes; Follow-Up Studies; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Male; Middle Aged; Practice Guidelines as Topic; Prisoners; Prisons; Program Evaluation; Sofosbuvir; Spain; Sustained Virologic Response; Uridine Monophosphate; Viral Load; Viremia; Young Adult | 2018 |
1 other study(ies) available for uridine monophosphate and Viremia
| Article | Year |
|---|---|
Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.
Topics: Adult; Antiviral Agents; Benzimidazoles; Cost-Benefit Analysis; Donor Selection; Drug Combinations; Female; Fluorenes; Hepatitis C, Chronic; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Outcome and Process Assessment, Health Care; Postoperative Complications; Pyrrolidines; Quinoxalines; Sofosbuvir; Sulfonamides; Uridine Monophosphate; Viremia | 2020 |